Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.6003579517912603e-30,23.419604205318493,1606.75640799281,"['RPL30', 'RPL10', 'RPL34', 'RPLP1', 'RPL12', 'RPL11', 'RPL36A', 'RPL10A', 'RPL9', 'RPS15', 'RPS14', 'RPS15A', 'RPL18A', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPS27A', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPL41', 'RPL21', 'RPS8', 'RPL35A', 'RPS3A', 'RPS26', 'RPS28', 'RPS27', 'RPS29', 'RPL24', 'RPL26', 'FAU', 'RPL29', 'RPS21', 'RPS24']",1.248279202397183e-28,0,0,37
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,9.819963277666229e-26,24.995941558441558,1439.3361794673535,"['COX7B', 'UQCRB', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'COX8A', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6']",3.82978567828983e-24,0,0,30
3,Nonalcoholic fatty liver disease WP4396,8.732735441758036e-19,15.311277330264671,636.6741174292049,"['NDUFA13', 'COX7B', 'UQCRB', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'CYCS']",2.2705112148570893e-17,0,0,26
4,Mitochondrial CIV Assembly WP4922,5.230136630428966e-12,32.007751937984494,831.452047708493,"['COX8A', 'COX7B', 'COX4I1', 'COX17', 'COX7A2', 'COX14', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1']",1.0198766429336485e-10,0,0,12
5,Mitochondrial complex III assembly WP4921,4.148715491225539e-07,46.46067415730337,682.7534002101595,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",6.47199616631184e-06,0,0,6
6,Oxidative phosphorylation WP623,1.9596853769305906e-06,8.75053214133674,115.00585170944608,"['NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFS6', 'NDUFB2', 'NDUFB1', 'ATP5MF', 'ATP5F1E', 'ATP5MC1']",2.5475909900097677e-05,0,0,10
7,Mitochondrial complex I assembly model OXPHOS system WP4324,4.535156012165513e-06,9.201242236024845,113.20887391193304,"['NDUFA13', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFS6', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1']",5.053459556413e-05,0,0,9
8,Pyrimidine metabolism WP4022,0.009131433436226258,4.417705199828105,20.74568760830908,"['NME2', 'POLR2I', 'POLR2J', 'POLR2K', 'POLR2L']",0.08400101995025483,0,0,5
9,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.010219859830762009,22.725274725274726,104.15953343764679,"['COX8A', 'COX5A']",0.08400101995025483,0,0,2
10,Proteasome Degradation WP183,0.010769361532083953,5.386928104575164,24.408440974171782,"['PSMB6', 'PSMD7', 'H2AFZ', 'PSMB10']",0.08400101995025483,0,0,4
11,Eukaryotic Transcription Initiation WP405,0.012566256735935243,7.6040515653775325,33.28095736463537,"['POLR2I', 'POLR2J', 'POLR2K']",0.08910618412754082,0,0,3
12,Copper homeostasis WP3286,0.03286920478218837,9.083516483516483,31.022198848086738,"['COX17', 'ATOX1']",0.2136498310842244,0,0,2
13,Composition of Lipid Particles WP3601,0.08334246996672472,22.60655737704918,56.172706316984545,['LPL'],0.4897478405202715,0,0,1
14,Alzheimer's disease WP2059,0.08790345855492053,3.10095429432446,7.540020380678709,"['ATP5MD', 'LPL', 'CYCS']",0.4897478405202715,0,0,3
15,Cytosolic DNA-sensing pathway WP4655,0.10337563776348387,4.122877122877123,9.356399441961747,"['POLR2K', 'POLR2L']",0.5375533163701162,0,0,2
16,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.12238522891463094,11.300546448087431,23.737719882161944,['LPL'],0.5966279909588258,0,0,1
17,Statin inhibition of cholesterol production WP430,0.15977371899868836,7.531876138433516,13.813436140946445,['LPL'],0.6304879657575858,0,0,1
18,Kallmann's Syndrome WP5074,0.15977371899868836,7.531876138433516,13.813436140946445,['ANOS1'],0.6304879657575858,0,0,1
19,MTHFR deficiency WP4288,0.15977371899868836,7.531876138433516,13.813436140946445,['CYCS'],0.6304879657575858,0,0,1
20,Genotoxicity pathway WP4286,0.16166358096348354,3.0205128205128204,5.504092527335043,"['PLK3', 'RPS27']",0.6304879657575858,0,0,2
21,Osteoclast Signaling WP12,0.1955776616233564,5.647540983606557,9.215644570023384,['CTSK'],0.6849872168931403,0,0,1
22,Triacylglyceride synthesis WP325,0.1955776616233564,5.647540983606557,9.215644570023384,['LPL'],0.6849872168931403,0,0,1
23,Nucleotide metabolism WP404,0.2298638576033279,4.516939890710383,6.641112489903725,['NME2'],0.6849872168931403,0,0,1
24,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.2298638576033279,4.516939890710383,6.641112489903725,['LPL'],0.6849872168931403,0,0,1
25,Fatty acid beta-oxidation WP143,0.2298638576033279,4.516939890710383,6.641112489903725,['LPL'],0.6849872168931403,0,0,1
26,Ciliary landscape WP4352,0.2606593582749041,1.5910331384015595,2.139209071842297,"['PSMD7', 'NDUFA5', 'MYL6B', 'COX6C']",0.6849872168931403,0,0,4
27,TP53 network WP1742,0.26269630719238585,3.7632058287795993,5.030490377493148,['SUMO1'],0.6849872168931403,0,0,1
28,Nanomaterial induced apoptosis WP2507,0.26269630719238585,3.7632058287795993,5.030490377493148,['CYCS'],0.6849872168931403,0,0,1
29,Androgen receptor signaling pathway WP138,0.27233737320777673,2.055944055944056,2.674194473765013,"['SUMO1', 'BAG1']",0.6849872168931403,0,0,2
30,Selenium Micronutrient Network WP15,0.28837510491572943,1.9660774008600095,2.444803876030726,"['SELENOW', 'SELENOH']",0.6849872168931403,0,0,2
31,Apoptosis Modulation by HSP70 WP384,0.29413632660453404,3.2248243559718968,3.9462560145750505,['CYCS'],0.6849872168931403,0,0,1
32,mRNA Processing WP411,0.3043734921143845,1.8836996336996337,2.2406602230103267,"['SNRPG', 'SRSF9']",0.6849872168931403,0,0,2
33,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.35307158480791406,2.5069823922282937,2.6099803919516105,['H2AFZ'],0.6849872168931403,0,0,1
34,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3656226261546709,1.219295958279009,1.22679896129488,"['RPL18A', 'SSR4', 'CYCS', 'RPLP2', 'RPL26', 'RPL10A', 'TMSB10']",0.6849872168931403,0,0,7
35,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3806770187477892,2.2557377049180327,2.178600460453332,['CYCS'],0.6849872168931403,0,0,1
36,Endothelin Pathways WP2197,0.3806770187477892,2.2557377049180327,2.178600460453332,['RIIAD1'],0.6849872168931403,0,0,1
37,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3806770187477892,2.2557377049180327,2.178600460453332,['CYCS'],0.6849872168931403,0,0,1
38,Monoamine GPCRs WP58,0.3806770187477892,2.2557377049180327,2.178600460453332,['HRH1'],0.6849872168931403,0,0,1
39,Development of ureteric collection system WP5053,0.3806770187477892,2.2557377049180327,2.178600460453332,['ANOS1'],0.6849872168931403,0,0,1
40,7q11.23 copy number variation syndrome WP4932,0.38295424910848014,1.557029177718833,1.4944984981815075,"['ATP5F1E', 'ATP5MC1']",0.6849872168931403,0,0,2
41,Integrated breast cancer pathway WP1984,0.38295424910848014,1.557029177718833,1.4944984981815075,"['PLK3', 'FAU']",0.6849872168931403,0,0,2
42,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4071106139999336,2.050173869846001,1.8424304724456195,['NDUFA13'],0.6849872168931403,0,0,1
43,Oxidative Damage WP3941,0.4071106139999336,2.050173869846001,1.8424304724456195,['CYCS'],0.6849872168931403,0,0,1
44,Parkinson's disease pathway WP2371,0.4071106139999336,2.050173869846001,1.8424304724456195,['CYCS'],0.6849872168931403,0,0,1
45,CAMKK2  Pathway WP4874,0.4071106139999336,2.050173869846001,1.8424304724456195,['FIS1'],0.6849872168931403,0,0,1
46,Type 2 papillary renal cell carcinoma WP4241,0.43242185432792857,1.878870673952641,1.5751580922154267,['CTSK'],0.6849872168931403,0,0,1
47,Vitamin A and carotenoid metabolism WP716,0.43242185432792857,1.878870673952641,1.5751580922154267,['LPL'],0.6849872168931403,0,0,1
48,AGE/RAGE pathway WP2324,0.4566581445954269,1.733921815889029,1.3590829626722554,['CYCS'],0.6849872168931403,0,0,1
49,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.4566581445954269,1.733921815889029,1.3590829626722554,['LPL'],0.6849872168931403,0,0,1
50,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4566581445954269,1.733921815889029,1.3590829626722554,['CTSK'],0.6849872168931403,0,0,1
51,MET in type 1 papillary renal cell carcinoma WP4205,0.4566581445954269,1.733921815889029,1.3590829626722554,['RPL11'],0.6849872168931403,0,0,1
52,PPAR signaling pathway WP3942,0.4566581445954269,1.733921815889029,1.3590829626722554,['LPL'],0.6849872168931403,0,0,1
53,Aryl Hydrocarbon Receptor Netpath WP2586,0.5233619864798178,1.4077868852459017,0.9115165548064116,['LPL'],0.7289684811683176,0,0,1
54,miRNA regulation of DNA damage response WP1530,0.5233619864798178,1.4077868852459017,0.9115165548064116,['CYCS'],0.7289684811683176,0,0,1
55,RANKL/RANK signaling pathway WP2018,0.5233619864798178,1.4077868852459017,0.9115165548064116,['CTSK'],0.7289684811683176,0,0,1
56,DNA damage response WP707,0.5233619864798178,1.4077868852459017,0.9115165548064116,['CYCS'],0.7289684811683176,0,0,1
57,EGF/EGFR signaling pathway WP437,0.5527031375667338,1.0980970249262931,0.6510993286107206,"['NDUFA13', 'NEDD8']",0.7555583697753856,0,0,2
58,IL-4 signaling pathway WP395,0.5632396692940441,1.2507589556769885,0.717998229890643,['HRH1'],0.7555583697753856,0,0,1
59,Acute viral myocarditis WP4298,0.5819158670150302,1.184641932700604,0.6413999709479172,['CYCS'],0.7555583697753856,0,0,1
60,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5819158670150302,1.184641932700604,0.6413999709479172,['CYCS'],0.7555583697753856,0,0,1
61,Translation Factors WP107,0.5997976092291453,1.125136612021858,0.5751282044603921,['EEF1B2'],0.7555583697753856,0,0,1
62,DNA Repair Pathways Full Network WP4946,0.6169185138928875,1.0712984647410877,0.517456797559941,['CENPX'],0.7555583697753856,0,0,1
63,Non-small cell lung cancer WP4255,0.6169185138928875,1.0712984647410877,0.517456797559941,['CYCS'],0.7555583697753856,0,0,1
64,Apoptosis WP254,0.6333107839344416,1.022354694485842,0.46700549792296825,['CYCS'],0.7555583697753856,0,0,1
65,IL-18 signaling pathway WP4754,0.635224030840587,0.9229546658593809,0.4188160958087894,"['NRN1', 'COX17', 'CYCS']",0.7555583697753856,0,0,3
66,22q11.2 copy number variation syndrome WP4657,0.6490052663455235,0.9776669042527917,0.42265952780234595,['MRPL40'],0.7555583697753856,0,0,1
67,Retinoblastoma gene in cancer WP2446,0.6490052663455235,0.9776669042527917,0.42265952780234595,['H2AFZ'],0.7555583697753856,0,0,1
68,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6784178156892491,0.899016393442623,0.34881110875337573,['LPL'],0.7669070959965424,0,0,1
69,Exercise-induced Circadian Regulation WP410,0.6784178156892491,0.899016393442623,0.34881110875337573,['SUMO1'],0.7669070959965424,0,0,1
70,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7053779210836992,0.8320178101598866,0.29039215531697415,['PSMD7'],0.7749222231623739,0,0,1
71,Mesodermal commitment pathway WP2857,0.7053779210836992,0.8320178101598866,0.29039215531697415,['RPL38'],0.7749222231623739,0,0,1
72,TGF-beta Signaling Pathway WP366,0.7180025621167764,0.8021077283372365,0.2657239659833389,['SUMO1'],0.777836108959841,0,0,1
73,Small cell lung cancer WP4658,0.7416601899731075,0.7482695810564663,0.22363091917136338,['CYCS'],0.7817499299716537,0,0,1
74,Apoptosis Modulation and Signaling WP1772,0.7416601899731075,0.7482695810564663,0.22363091917136338,['CYCS'],0.7817499299716537,0,0,1
75,Adipogenesis WP236,0.7925193919018129,0.6405932864949259,0.1489624765576001,['LPL'],0.8242201675778854,0,0,1
76,"GPCRs, Class A Rhodopsin-like WP455",0.8405695708050347,0.5460482473677196,0.09483523320562492,['HRH1'],0.8584290181654931,0,0,1
77,Hepatitis B infection WP4666,0.8474235179326023,0.5329169919333854,0.08822690639716867,['CYCS'],0.8584290181654931,0,0,1
78,Circadian rhythm related genes WP3594,0.882810059556792,0.4656193078324226,0.05803721622181238,['RPS27A'],0.882810059556792,0,0,1
